AM 0902

Ref.: BL-RE-160759 50 mg
€711.64 excl. VAT

Potent and selective TRPA1 antagonist

Supplier ref.: 18709827

Chemical name or material
1-[[3-[2-(4-Chlorophenyl)ethyl]-1,2,4-oxadiazol-5-yl]methyl]-1,7-dihydro-7-methyl-6H-purin-6-one
CAS
1883711-97-4
Percentage range of dosage
>98%
Quantity
50 mg
Molecular formula
C17H15ClN6O2
Brand
Tocris Bioscience

AM 0902 is a potent and selective TRPA1 antagonist (IC50 = 0.02 μM for human TRPA1). Exhibits no siginificant activity against human TRPV1 or TRPV4, and rat TRPV1, TRPV3 or TRPM8. Exhibits efficacy in a rat pain model. Orally bioavailable.

Technical specifications

BrandTocris Bioscience
B-LABO ref.BL-RE-160759
Chemical name or material1-[[3-[2-(4-Chlorophenyl)ethyl]-1,2,4-oxadiazol-5-yl]methyl]-1,7-dihydro-7-methyl-6H-purin-6-one
CAS1883711-97-4
Percentage range of dosage>98%
Quantity50 mg
Molecular formulaC17H15ClN6O2
Weight of formulaObserved MW: 370.79
A question or a specific configuration?
Contact us for a quote.

Supplier ref.: 18709827